Form D · Biotechnology

CytoStorm, Inc.

Laguna Hills, CA · CIK 0001750289

Offering snapshot reported Sep 28, 2018 · SEC filing

Reported sold
$100K
Offering amount: $400K
Investors reported
2
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Sep 15, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$50K$100KAug 21, 2018: $50,000.00Aug 21, 2018Sep 28, 2018: $100,000.00Sep 28, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$50,000 → $100,000
  • Reported investors1 → 2

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 28, 2018Amendment$100,000$50,000vs Aug 21, 20182SEC filing
Aug 21, 2018Initial$50,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$40K (estimated)
Form D file number
021-319659
Series A Preferred Stock

Source: Form D, filed Sep 28, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ruldolph C. Shepard Director, Executive
Rudolph C. Shepard Director, Executive
Lon H. Stone Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
26042 Merit Circle, Ste 104
Laguna Hills, CA, 92653